|
|
 |
|
Viewing report
|
|
|
|
Allergies and Allergy Remedies in the United States 2009
Mintel, Feb 2009, Pages: 96
The U.S. OTC allergy remedy market is driven by a range of factors, preeminently the incidence of allergies, which afflict an estimated 50 million sufferers, according to the American Academy of Asthma Allergy & Immunology. The most important internal driver for sales of these products is the Rx-to-OTC switch of allergy remedies, which have infused the market with substantial revenue and aided growth between 2003 and 2008. Mintel’s report provides an in-depth analysis of these drivers, as well as a complete examination of the following features of the market:
- The role of the child and elderly populations, which are specifically susceptible to allergies, and are forecast to increase in number in the coming years
- The self-diagnosis/self-medication movement in the U.S., which brings more consumers to the OTC aisle
- Growth of the allergy remedy market within the larger cold/allergy/sinus remedy market
- How the impact of Rx switches has allowed a select handful of companies to dominate sales
- Marketing of brand qualities and the attempt to position remedies as time-saving, clarity-providing and life-enhancing
Customers who bought this item also bought
Allergy Drugs - Global Strategic Business Report
Cold Flu and Allergy Remedies in the United States 2007
Cold, Cough, And Sore Throat Remedies - Global Strategic Business Report
Private Label OTC Healthcare in the United States 2010
Nicholas Hall's Global Cough, Cold & Allergy Review
OTC Pediatrics in the United States 2010
Intranasal Drug Delivery - Global Strategic Business Report
Nicholas Hall's OTC YearBook 2011 Report
Pediatric Drug Delivery: Technology and Product Opportunities, 2nd Edition
The Pharmaceuticals Consumer in the United States 2010
|
|
|
|
